Skip to main content
. 2009 Jan-Jun;2(1):41–50. doi: 10.4103/0974-2069.52806

Table 1.

Summary of risk factors that should prompt detailed cardiac evaluation

Fetal factors
 Suspected cardiac abnormality on screening ultrasound
 Increased nuchal translucency thickness
 Fetal hydrops
 Fetal abnormality with known association of congenital heart disease
 e.g., exomphalos, diaphragmatic hernia
 Fetal arrhythmia
 Abnormal fetal karyotype, e.g., trisomy 21
Maternal and familial risk factors
 Family history of congenital heart disease (CHD) in a first degree relative.
 Diabetes mellitus – Mothers who are established diabetics on treatment
 Mothers with a tendency toward diabetes that is solely related to pregnancy are not judged candidates for fetal echocardiography
 Mothers taking known teratogenic drugs, e.g., anticonvulsants, lithium
 Maternal anti - Ro or anti - La antibodies
 Mothers who have anti-Ro and / or La antibodies are candidates for fetal cardiology assessment, in view of the risk of developing fetal heart block. Mothers NOT having anti Ro or La antibodies are not candidates for fetal echocardiography
 Maternal infections, e.g., parvovirus, Coxsackie